CSIMarket
 


Lipocine Inc   (LPCN)
Other Ticker:  
 


Lipocine Inc 's EBITDA Margin by quarter

Trends, Rankings, Statistics



LPCN EBITDA Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 164.58 % - -97.47 % - -99.78 %
Seq. Revenue Change - - -82.07 % 347.17 % -89.5 %
Revenue In Millions $0.09 $-3.12 $0.03 $0.15 $0.03
EBITDA Margin -2509.62 % - -12895.79 % -2524.24 % -6503.09 %
EBITDA Margin Total Ranking # # # # #
EBITDA In Millions $-2.27 $-6.64 $-3.54 $-3.87 $-2.23
Y / Y EBITDA Change - - - - -
Seq. EBITDA Change - - - - -


Commenting fourth Quarter 2023 EBITDA Margin
Lipocine Inc Operating Loss of -2 fell compare to Operating Loss of $-6.64 millions a quarter before.

Observing fourth quarter 2023 results within Major Pharmaceutical Preparations industry Lipocine Inc has achieved highest EBITDA Margin. While overall EBITDA Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Operating Margin
LPCN's EBITDA Margin fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall # 0

EBITDA Margin Statistics
High Average Low
81.24 % 81.24 % 81.24 %
(Dec 31 2021)  




Other EBITDA Margin Profitability Ratios
LPCN's Cumulative EBITDA Margin
Major Pharmaceutical Preparations Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
LPCN's EBITDA Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for LPCN's Competitors
EBITDA Margin Profit Margin for Lipocine Inc 's Suppliers
EBITDA Margin Profit Margin for LPCN's Customers

You may also want to know
LPCN's Annual Growth Rates LPCN's Profitability Ratios LPCN's Asset Turnover Ratio LPCN's Dividend Growth
LPCN's Roe LPCN's Valuation Ratios LPCN's Financial Strength Ratios LPCN's EBITDA Growth
LPCN's Roa LPCN's Inventory Turnover Ratio LPCN's Growth Rates LPCN's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry EBITDA MarginDec 31 2023 MRQ EBITDADec 31 2023 MRQ Revenue




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com